Met Life Investment Management, LLC Verastem, Inc. Transaction History

Met Life Investment Management, LLC

  • $17.1 Billion
  • Q3 2024

Shares

41 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022
SELL
$1.02 - $1.83 $49,514 - $88,835
-48,544 Closed
0 $0
Q1 2022

May 10, 2024
BUY
$1.06 - $2.1 $51,456 - $101,942
48,544 New
48,544 $68,000
Q1 2022

Jun 20, 2023
BUY
$1.06 - $2.1 $51,456 - $101,942
48,544 New
48,544 $68,000
Q1 2022

Mar 22, 2023
SELL
$1.06 - $2.1 $17,659 - $34,986
-16,660 Reduced 25.55%
48,544 $68,000
Q1 2022

May 12, 2022
SELL
$1.06 - $2.1 $17,659 - $34,986
-16,660 Reduced 25.55%
48,544 $68,000
Q4 2021

May 17, 2024
BUY
$2.05 - $3.2 $61,350 - $95,766
29,927 Added 84.83%
65,204 $133,000
Q4 2021

Jun 21, 2023
BUY
$2.05 - $3.2 $133,668 - $208,652
65,204 New
65,204 $133,000
Q4 2021

Mar 22, 2023
BUY
$2.05 - $3.2 $61,350 - $95,766
29,927 Added 84.83%
65,204 $133,000
Q4 2021

Feb 15, 2022
BUY
$2.05 - $3.2 $61,350 - $95,766
29,927 Added 84.83%
65,204 $134,000
Q3 2021

May 17, 2024
SELL
$2.54 - $4.07 $77,249 - $123,780
-30,413 Reduced 46.3%
35,277 $108,000
Q3 2021

Jun 21, 2023
BUY
$2.54 - $4.07 $89,603 - $143,577
35,277 New
35,277 $108,000
Q3 2021

Mar 22, 2023
SELL
$2.54 - $4.07 $77,249 - $123,780
-30,413 Reduced 46.3%
35,277 $108,000
Q3 2021

Nov 15, 2021
SELL
$2.54 - $4.07 $77,249 - $123,780
-30,413 Reduced 46.3%
35,277 $109,000
Q2 2021

May 17, 2024
BUY
$2.57 - $4.85 $106,860 - $201,662
41,580 Added 172.46%
65,690 $267,000
Q2 2021

Jun 21, 2023
BUY
$2.57 - $4.85 $168,823 - $318,596
65,690 New
65,690 $267,000
Q2 2021

Mar 22, 2023
BUY
$2.57 - $4.85 $106,860 - $201,662
41,580 Added 172.46%
65,690 $267,000
Q2 2021

Aug 16, 2021
BUY
$2.57 - $4.85 $106,860 - $201,662
41,580 Added 172.46%
65,690 $267,000
Q1 2021

May 17, 2024
BUY
$1.9 - $2.82 $45,809 - $67,990
24,110 New
24,110 $59,000
Q1 2021

Jun 26, 2023
BUY
$1.9 - $2.82 $45,809 - $67,990
24,110 New
24,110 $59.6 Million
Q1 2021

Mar 22, 2023
SELL
$1.9 - $2.82 $103,139 - $153,080
-54,284 Reduced 69.25%
24,110 $59,000
Q1 2021

May 14, 2021
SELL
$1.9 - $2.82 $103,139 - $153,080
-54,284 Reduced 69.25%
24,110 $60,000
Q4 2020

May 24, 2024
BUY
$1.15 - $2.4 $71,762 - $149,764
62,402 Added 390.21%
78,394 $166,000
Q4 2020

Jun 22, 2023
BUY
$1.15 - $2.4 $90,153 - $188,145
78,394 New
78,394 $166,000
Q4 2020

Mar 22, 2023
BUY
$1.15 - $2.4 $71,762 - $149,764
62,402 Added 390.21%
78,394 $166,000
Q4 2020

Feb 16, 2021
BUY
$1.15 - $2.4 $71,762 - $149,764
62,402 Added 390.21%
78,394 $167,000
Q3 2020

May 24, 2024
SELL
$1.11 - $1.68 $71,941 - $108,884
-64,812 Reduced 80.21%
15,992 $19.4 Million
Q3 2020

Jun 26, 2023
BUY
$1.11 - $1.68 $17,751 - $26,866
15,992 New
15,992 $19,000
Q3 2020

Mar 22, 2023
SELL
$1.11 - $1.68 $71,941 - $108,884
-64,812 Reduced 80.21%
15,992 $19,000
Q3 2020

Nov 13, 2020
SELL
$1.11 - $1.68 $71,941 - $108,884
-64,812 Reduced 80.21%
15,992 $19,000
Q2 2020

May 24, 2024
BUY
$1.69 - $4.2 $136,558 - $339,376
80,804 New
80,804 $139 Million
Q2 2020

Jun 26, 2023
BUY
$1.69 - $4.2 $136,558 - $339,376
80,804 New
80,804 $138,000
Q2 2020

Mar 22, 2023
BUY
$1.69 - $4.2 $91,449 - $227,270
54,112 Added 202.73%
80,804 $138,000
Q2 2020

Aug 14, 2020
BUY
$1.69 - $4.2 $136,558 - $339,376
80,804 New
80,804 $139,000
Q1 2019

May 15, 2019
SELL
$2.79 - $4.09 $74,470 - $109,170
-26,692 Closed
0 $0
Q4 2018

Jul 13, 2023
BUY
$3.23 - $7.01 $86,215 - $187,110
26,692 New
26,692 $89,000
Q4 2018

Mar 22, 2023
SELL
$3.23 - $7.01 $59,383 - $128,878
-18,385 Reduced 40.79%
26,692 $89,000
Q4 2018

Feb 14, 2019
SELL
$3.23 - $7.01 $59,383 - $128,878
-18,385 Reduced 40.79%
26,692 $90,000
Q3 2018

Jul 13, 2023
BUY
$6.86 - $9.97 $183,107 - $266,119
26,692 New
26,692 $193,000
Q3 2018

Mar 22, 2023
BUY
$6.86 - $9.97 $309,228 - $449,417
45,077 New
45,077 $326,000
Q3 2018

Nov 14, 2018
BUY
$6.86 - $9.97 $126,121 - $183,298
18,385 Added 68.88%
45,077 $327,000
Q2 2018

Aug 15, 2018
BUY
$2.88 - $8.67 $76,872 - $231,419
26,692 New
26,692 $184,000

Others Institutions Holding VSTM

# of Institutions
5
Shares Held
297K
Call Options Held
0
Put Options Held
0
View Full List

About Verastem, Inc.

VSTM Quotes by TradingView
  • Ticker VSTM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 210,000,000
  • Market Cap $838M
  • Description
  • Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...
More about VSTM
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email